Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 8:00 AM ET

Date/Time Source News Release
05/12/2025 06:05 PM EDT Newsfile Marvel Biosciences Announces Closing of Private Placement
05/02/2025 07:00 AM EDT Newsfile Marvel Biosciences Announces Closing of Second Tranche of Private Placement
04/30/2025 07:00 AM EDT Newsfile Marvel Announces the Second of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide Following Cessation of Drug Treatment
04/16/2025 07:00 AM EDT Newsfile Marvel Biosciences to Give Oral Presentation at The Annual IRSF Rett Syndrome Scientific Meeting
04/14/2025 07:00 AM EDT Newsfile Marvel Biosciences Selected to Present Alzheimer's Research at the 2025 Alzheimer's Association International Conference
03/28/2025 04:30 PM EDT Newsfile Marvel Biosciences Announces Private Placement
03/17/2025 07:00 AM EDT Newsfile Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome
03/13/2025 07:00 AM EDT Newsfile Marvel Announces First of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide
03/11/2025 07:00 AM EDT Newsfile Marvel Presenting at the 2025 Bloom Burton & Co. Conference
01/16/2025 07:00 AM EST Newsfile Marvel Biosciences Announces Notice of Allowance of Composition of Matter Patent for Its Lead Molecule MB-204 in China
Page

Additional News

As of June 14, 2025 • 8:00 AM ET

Date/Time Source News Release
02/28/2025 09:10 AM EST InvestorIdeas.com New Biotech Stocks at Investorideas.com
04/20/2023 09:15 AM EDT Baystreet Stocks in Play: Marvel Biosciences Corp
03/22/2023 09:10 AM EDT Baystreet Help is on the Way as Rising Alzheimer's Cases Highlight Urgency for New Treatments
12/07/2022 09:40 AM EST Baystreet Stocks in Play: Marvel Biosciences Corp
11/25/2022 09:32 AM EST Baystreet Stocks in Play: Marvel Biosciences Corp
11/22/2022 05:44 PM EST y%wire Canadian Micro Cap Gets Boost Following Study Findings
11/14/2022 09:15 AM EST Financial News Media Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates
11/01/2022 09:22 AM EDT Baystreet Stocks in Play: Marvel Biosciences Corp
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.